vudalimab
xencor
['carboplatin', 'ability,(-inability)', 'vudalimab', 'imab ', '$xncr', 'xencor']
#sitc22 updates: xencors's #vudalimab (pd-1 x ctla-4 bsab) showed initial clinical activity (&gt;50% psa reduction: 3/9 pts) in combination with carboplatin + taxane in mcrpc; hard in terms of tolerability -&gt; chemo dosing regimens to be modified
$xncr #prostatecancer #cancerresearch 
Course5i prides itself in enabling #LifeSciences organizations with insights, #analytics and #AI to drive strategic decisions. Enabling better health outcomes.